We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Psychiatry

Psychiatry

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Regional Specificity of Layer 3 Dendritic Spine Deficits in Schizophrenia: Implications for Cortical Circuit Dysfunction
Neurologyschizophrenia

Regional Specificity of Layer 3 Dendritic Spine Deficits in Schizophrenia: Implications for Cortical Circuit Dysfunction

By MedXY|Oct 27, 2025

This study reveals region- and size-specific dendritic spine deficits in cortical layer 3 neurons of schizophrenia patients, highlighting differential synaptic disruptions across visual and prefrontal cortical areas underpinning cognitive d

Gamified mHealth Strategies Boost Treatment Adherence and Outcomes in Late-Life Depression
newsdepressionmHealth

Gamified mHealth Strategies Boost Treatment Adherence and Outcomes in Late-Life Depression

By MedXY|Oct 27, 2025

Implementing gamification in mobile health psychotherapy markedly improves adherence and reduces depressive symptoms among older adults, offering a promising avenue to address mental health care needs in aging populations.

Evaluating Pramipexole as Adjunct Therapy in Treatment-Resistant Bipolar Depression: Insights from the PAX-BD Trial
newsBipolar DepressionPramipexole

Evaluating Pramipexole as Adjunct Therapy in Treatment-Resistant Bipolar Depression: Insights from the PAX-BD Trial

By MedXY|Oct 24, 2025

The PAX-BD trial assessed pramipexole addition to mood stabilisers in treatment-resistant bipolar depression, revealing some mood and psychosocial benefits but no significant primary outcome improvement, highlighting the need for further re

Evaluating Serial Ketamine Infusions as Adjuncts in Inpatient Depression Care: Insights from the KARMA-Dep 2 Trial
newsKetaminemajor depression

Evaluating Serial Ketamine Infusions as Adjuncts in Inpatient Depression Care: Insights from the KARMA-Dep 2 Trial

By MedXY|Oct 24, 2025

The KARMA-Dep 2 trial reveals that serial ketamine infusions do not significantly outperform midazolam in reducing depressive symptoms among inpatients receiving usual psychiatric care, challenging assumptions about ketamine’s long-term ant

Silent Long-Term Harm: How Prenatal Lead Exposure Shapes Adult Mental Health
Pediatricslead exposuremental health

Silent Long-Term Harm: How Prenatal Lead Exposure Shapes Adult Mental Health

By MedXY|Oct 24, 2025

This article explores the link between prenatal and early postnatal lead exposure and adult anxiety and depression, emphasizing critical exposure windows and long-term mental health implications.

Unlocking the Complexity of Co-Occurring Chronic Pain and Psychological Distress in Young Adults: Insights from Machine Learning and Explainable AI
newschronic painmachine learning

Unlocking the Complexity of Co-Occurring Chronic Pain and Psychological Distress in Young Adults: Insights from Machine Learning and Explainable AI

By MedXY|Oct 24, 2025

This study applies machine learning and explainable AI to identify factors associated with chronic pain, psychological distress, and their co-occurrence in Norwegian young adults, highlighting the importance of integrated approaches for ear

Long-Term Exposure to Air Pollution and Road Traffic Noise: Associations with Antidepressant Medication Dispensing in Swedish Adults
Clinical Updatesair pollutionantidepressants

Long-Term Exposure to Air Pollution and Road Traffic Noise: Associations with Antidepressant Medication Dispensing in Swedish Adults

By MedXY|Oct 23, 2025

This review synthesizes evidence linking long-term air pollution and road traffic noise exposure with antidepressant medication dispensing, highlighting sex-specific associations and implications for mental health prevention strategies.

Long-Term PM2.5 Exposure and Mental Health Disparities: Insights from the All of Us Research Program
Psychiatryanxietydepression

Long-Term PM2.5 Exposure and Mental Health Disparities: Insights from the All of Us Research Program

By MedXY|Oct 23, 2025

This prospective study reveals that prolonged exposure to fine particulate matter (PM2.5) significantly elevates risks of depression and anxiety, disproportionately affecting Black populations due to systemic inequities. Findings call for t

Reducing Suicide Risk in Bipolar Disorder: The Impact of Lithium, Valproate, and Atypical Antipsychotics in Long-Term Treatment
Psychiatrylithiumsuicide risk

Reducing Suicide Risk in Bipolar Disorder: The Impact of Lithium, Valproate, and Atypical Antipsychotics in Long-Term Treatment

By MedXY|Oct 23, 2025

This study reveals that long-term treatment with lithium or valproate significantly lowers suicide risks in bipolar disorder patients. Combining atypical antipsychotics with these mood stabilizers further reduces suicide incidence, offering

Decoding Conspiratorial Thinking Across America: Insights from a Nationwide Survey
PsychiatryCOVID-19 vaccinationmental health

Decoding Conspiratorial Thinking Across America: Insights from a Nationwide Survey

By MedXY|Oct 22, 2025

A comprehensive 50-state survey reveals widespread conspiratorial thinking among American adults linked to demographic factors and COVID-19 vaccine hesitancy, with implications for public health strategies.

Semaglutide for Metabolic Health in Schizophrenia: Insights from the HISTORI RCT
Diabetes & Endocrinologyobesityprediabetes

Semaglutide for Metabolic Health in Schizophrenia: Insights from the HISTORI RCT

By MedXY|Oct 22, 2025

The HISTORI trial demonstrates that semaglutide significantly improves glycemic control, reduces weight, and enhances physical quality of life in schizophrenia patients treated with second-generation antipsychotics, without worsening psychi

Azetukalner: A Novel KV7 Potassium Channel Opener Shows Promise in Treating Major Depressive Disorder
newsAnhedoniamajor depressive disorder

Azetukalner: A Novel KV7 Potassium Channel Opener Shows Promise in Treating Major Depressive Disorder

By MedXY|Oct 21, 2025

Azetukalner, a KV7 potassium channel opener, demonstrated clinically meaningful antidepressant effects and significant improvement in anhedonia in adults with major depressive disorder in a 6-week randomized trial, supporting further develo

Single-Dose MM120 (Lysergide) Shows Promise in Treating Generalized Anxiety Disorder: Phase 2b RCT Results
Internal MedicineGeneralized Anxiety Disorderrandomized clinical trial

Single-Dose MM120 (Lysergide) Shows Promise in Treating Generalized Anxiety Disorder: Phase 2b RCT Results

By MedXY|Oct 21, 2025

A phase 2b trial reveals that single doses of MM120 produce dose-dependent reductions in anxiety symptoms in adults with moderate to severe generalized anxiety disorder, paving the way for phase 3 studies.

Amygdala Tau Pathology as a Key Contributor to Depressive Symptoms in Aging: Insights from Neuroimaging Studies
Neurologyagingamygdala

Amygdala Tau Pathology as a Key Contributor to Depressive Symptoms in Aging: Insights from Neuroimaging Studies

By MedXY|Oct 21, 2025

Amygdala tau accumulation in cognitively normal older adults correlates with worsening depressive symptoms, especially in APOE ε4 carriers, highlighting its role in neuropsychiatric changes during aging.

Global Trends and Method-Specific Suicide Mortality Among Older Adults: Insights and Projections to 2050
newsglobal healtholder adults

Global Trends and Method-Specific Suicide Mortality Among Older Adults: Insights and Projections to 2050

By MedXY|Oct 20, 2025

A comprehensive study spanning 47 countries reveals changing suicide mortality rates among adults aged 65+, highlighting method-specific risks and projecting future trends amid global population ageing.

Enhancing Suicide Prevention Skills in Older Men Through Community-Based Training: Evidence from a Cluster RCT of the Conversations about Suicide Course in Australian Men’s Sheds
Psychiatrycommunity interventionolder men

Enhancing Suicide Prevention Skills in Older Men Through Community-Based Training: Evidence from a Cluster RCT of the Conversations about Suicide Course in Australian Men’s Sheds

By MedXY|Oct 20, 2025

A cluster randomised controlled trial demonstrates that the Conversations about Suicide course delivered in Australian Men’s Sheds significantly improves recommended suicide prevention actions among older men, with sustained effects a

Early Adolescent Mental Well-Being as a Predictor of Long-Term Health Outcomes
Psychiatryadolescent mental healthlong-term outcomes

Early Adolescent Mental Well-Being as a Predictor of Long-Term Health Outcomes

By MedXY|Oct 18, 2025

This study highlights how poor mental well-being during adolescence predicts increased risks of mental illness, risky behaviors, and mortality in young adulthood, emphasizing the urgency for early identification and intervention.

Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Older Adults with Schizophrenia: Insights from Hong Kong’s Population-Based Study
Internal Medicineadverse eventsantipsychotics

Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Older Adults with Schizophrenia: Insights from Hong Kong’s Population-Based Study

By MedXY|Oct 18, 2025

This study compares long-acting injectable to oral antipsychotics in older schizophrenia patients, highlighting benefits in relapse prevention and mortality reduction, with specific considerations for adverse effects.

Evaluating the Effectiveness of Circle of Security-Parenting for Perinatal Mental Health: Insights from a Large-Scale RCT
OB/GYN & Women's Healthparenting interventionrandomized controlled trial

Evaluating the Effectiveness of Circle of Security-Parenting for Perinatal Mental Health: Insights from a Large-Scale RCT

By MedXY|Oct 18, 2025

This study finds no significant benefit of the Circle of Security-Parenting intervention added to usual care for improving mental health and bonding among new parents in NHS settings.

Rising Trends in Non-Lethal Self-Harm and Suicide in Spain (2018-2023): A Nationwide Registry Analysis with a Focus on Age and Gender
Psychiatryepidemiologymental health

Rising Trends in Non-Lethal Self-Harm and Suicide in Spain (2018-2023): A Nationwide Registry Analysis with a Focus on Age and Gender

By MedXY|Oct 18, 2025

A nationwide study in Spain from 2018 to 2023 reveals increasing rates of non-lethal intentional self-harm and suicide, particularly among young women, underscoring the need for targeted mental health interventions.

Prev
14 / 20
1…1213141516…20
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles